YOU ARE EXPLORING
Clint Cary, MPH, MD
Assistant Professor of Urology
Dr. Cary completed his urology residency at Indiana University and then went on to complete a two year urologic oncology fellowship at the University of California, San Francisco. In addition to his fellowship, he completed a Master of Public Health Degree from U.C. Berkeley with a concentration in epidemiology. His clinical interest is in urologic oncology with a focus on the surgical managment of advanced testicular cancer and bladder cancer. His research efforts focus on health services and outcomes research in testis and bladder cancer.
RT 420 UROL
Dr. Cary's primary research interest involves testicular cancer. He has published numerous peer-reviewed publications describing the surgical management and outcomes in patients with advanced germ cell tumors. He is currently involved with several projects including a Pilot study in patients with clinical stage I testicular cancer to understand how they make treatment decisions. He is also the site Principal Investigator for the multi-institutional Phase II RPLND trial in patients with early metastatic seminoma.
Additionally, Dr. Cary is funded through the National Cancer Institute by a K23 Career Development Award over 5-years. His grant evaluates patterns of care in patients with non-muscle invasive bladder cancer who received mitomycin C and to develop and implement interventions to improve access to this therapy.
Finally, he is the Director of the Cancer Health Equities Center at the Indiana University Melvin and Bren Simon Cancer Center. In this role, he unites cancer researchers across IU campuses including Purdue and Notre Dame to address cancer health disparities across the state of Indiana through research, policy, and community engagement.